Functional Interaction of Plasmacytoid Dendritic Cells with Multiple Myeloma Cells: A Therapeutic Target

被引:227
作者
Chauhan, Dharminder [1 ,2 ]
Singh, Ajita V. [1 ,2 ]
Brahmandam, Mohan [1 ,2 ]
Carrasco, Ruben [1 ,2 ]
Bandi, Madhavi [1 ,2 ]
Hideshima, Teru [1 ,2 ]
Bianchi, Giada [1 ,2 ]
Podar, Klaus [1 ,2 ]
Tai, Yu-Tzu [1 ,2 ]
Mitsiades, Constantine [1 ,2 ]
Raje, Noopur [1 ,2 ]
Jaye, David L. [3 ]
Kumar, Shaji K. [4 ]
Richardson, Paul [1 ,2 ]
Munshi, Nikhil [5 ]
Anderson, Kenneth C. [1 ,2 ]
机构
[1] Harvard Univ, Sch Med, LeBow Inst Myeloma Therapeut, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Jerome Lipper Ctr Myeloma Res,Dept Med Oncol, Boston, MA 02115 USA
[3] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
[4] Mayo Clin, Dept Hematol, Rochester, MN 55905 USA
[5] Harvard Univ, Sch Med, Vet Adm Boston Healthcare Syst, Boston, MA 02115 USA
关键词
INTERFERON-PRODUCING CELLS; REGULATORY T-CELLS; BONE-MARROW; NUCLEIC-ACIDS; HUMAN BLOOD; EXPRESSION; SURVIVAL; INDUCE; DIFFERENTIATION; INTERLEUKIN-6;
D O I
10.1016/j.ccr.2009.08.019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Multiple myeloma (MM) remains incurable despite novel therapies, suggesting the need for further identification of factors mediating tumorigenesis and drug resistance. Using both in vitro and in vivo MM xenograft models, we show that plasmacytoid dendritic cells (pDCs) in the bone marrow (BM) microenvironment both mediate immune deficiency characteristic of MM and promote MM cell growth, survival, and drug resistance. Microarray, cell signaling, cytokine profile, and immunohistochemical analysis delineate the mechanisms mediating these sequelae. Although pDCs are resistant to novel therapies, targeting Toll-like receptors with CpG oligodeoxynucleotides both restores pDC immune function and abrogates pDC-induced MM cell growth. Our study therefore validates targeting pDC-MM interactions as a therapeutic strategy to overcome drug resistance in MM.
引用
收藏
页码:309 / 323
页数:15
相关论文
共 49 条
[1]   Targeted therapy of multiple myeloma based upon tumor-microenvironmental interactions [J].
Anderson, Kenneth C. .
EXPERIMENTAL HEMATOLOGY, 2007, 35 (04) :155-162
[2]   Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients [J].
Banerjee, Devi K. ;
Dhodapkar, Madhav V. ;
Matayeva, Elyana ;
Steinman, Ralph M. ;
Dhodapkar, Kavita M. .
BLOOD, 2006, 108 (08) :2655-2661
[3]   Nucleic acids of mammalian origin can act as endogenous ligands for toll-like receptors and may promote systemic lupus erythematosus [J].
Barrat, FJ ;
Meeker, T ;
Gregorio, J ;
Chan, JH ;
Uematsu, S ;
Akira, S ;
Chang, B ;
Duramad, O ;
Coffman, RL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (08) :1131-1139
[4]   Molecular pathogenesis and a consequent classification of multiple myeloma [J].
Bergsagel, PL ;
Kuehl, WM .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (26) :6333-6338
[5]   Recent major improvement in long-term survival of younger patients with multiple myeloma [J].
Brenner, Hermann ;
Gondos, Adam ;
Pulte, Dianne .
BLOOD, 2008, 111 (05) :2521-2526
[6]   Impaired functionality and phenotypic profile of dendritic cells from patients with multiple myeloma [J].
Brimnes, MK ;
Svane, IM ;
Johnsen, HE .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 144 (01) :76-84
[7]   Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-β1 and interleukin-10 [J].
Brown, RD ;
Pope, B ;
Murray, A ;
Esdale, W ;
Sze, DM ;
Gibson, J ;
Ho, PJ ;
Hart, D ;
Joshua, D .
BLOOD, 2001, 98 (10) :2992-2998
[8]   A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib [J].
Chauhan, D ;
Catley, L ;
Li, GL ;
Podar, K ;
Hideshima, T ;
Velankar, M ;
Mitsiades, C ;
Mitsiades, N ;
Yasui, H ;
Letai, A ;
Ovaa, H ;
Berkers, C ;
Nicholson, B ;
Chao, TH ;
Neuteboom, STC ;
Richardson, P ;
Palladino, MA ;
Anderson, KC .
CANCER CELL, 2005, 8 (05) :407-419
[9]   Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B [J].
Chauhan, D ;
Uchiyama, H ;
Akbarali, Y ;
Urashima, M ;
Yamamoto, K ;
Libermann, TA ;
Anderson, KC .
BLOOD, 1996, 87 (03) :1104-1112
[10]   Plasmacytoid dendritic cells in immunity [J].
Colonna, M ;
Trinchieri, G ;
Liu, YJ .
NATURE IMMUNOLOGY, 2004, 5 (12) :1219-1226